Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Dalmelitinib | 1637658-98-0 | 98.7% | 461.47 | 25 MG
Supplier: Medchemexpress LLC 25MGHY147259
Dalmelitinib is an orally active, selective c-Met kinase inhibitor that binds to the ATP-binding region of c-Met. It induces MET phosphorylation and inhibits AKT and ERK phosphorylation. Dalmelitinib potently inhibits cancer cell proliferation and is used in research for cancers such as human non-small cell lung cancer (NSCLC).
- Orally active selective c-Met kinase inhibitor
- Binds to the ATP-binding region of c-Met
- Induces phosphorylation of MET
- Inhibits phosphorylation of AKT and ERK
- Potently inhibits cancer cell proliferation
- Used for research of human non-small cell lung cancer
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?